Shionogi, Inc
- Country
- π―π΅Japan
- Ownership
- -
- Established
- 1919-01-01
- Employees
- -
- Market Cap
- $13.1B
A Study of S-892216 in Participants With COVID-19
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Shionogi
- Target Recruit Count
- 280
- Registration Number
- NCT06928051
A Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants
- First Posted Date
- 2025-01-15
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Shionogi
- Target Recruit Count
- 24
- Registration Number
- NCT06775730
- Locations
- πΊπΈ
Early Phase Clinical Unit Los Angeles, Glendale, California, United States
A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Shionogi
- Target Recruit Count
- 16
- Registration Number
- NCT06751017
- Locations
- πΊπΈ
ICON Lenexa, Lenexa, Kansas, United States
A Study to Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric Participants
- Conditions
- RSV Infections
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Shionogi
- Target Recruit Count
- 100
- Registration Number
- NCT06746051
- Locations
- πΊπΈ
SUNY Upstate Medical University, Syracuse, New York, United States
πΊπΈSeattle Children's Hospital, Seattle, Washington, United States
A Study of S-740792 in Healthy Adult Study Participants
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Shionogi
- Target Recruit Count
- 116
- Registration Number
- NCT06724978
- Locations
- πΊπΈ
Fortrea Clinical Research Unit, Inc., Daytona Beach, Florida, United States
Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS])
- Conditions
- Jordan's SyndromePPP2R5D Neurodevelopmental Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Shionogi
- Target Recruit Count
- 30
- Registration Number
- NCT06717438
- Locations
- πΊπΈ
Rush University Medical Center, Chicago, Illinois, United States
πΊπΈBoston Children's Hospital, Boston, Massachusetts, United States
πΊπΈSeattle Children's Hospital, Seattle, Washington, United States
A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants
- First Posted Date
- 2024-02-21
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Shionogi
- Target Recruit Count
- 50
- Registration Number
- NCT06270511
- Locations
- πΊπΈ
ICON Lenexa, Lenexa, Kansas, United States
Effect of Administration of Itraconazole on the Pharmacokinetics of S-309309 in Healthy Participants
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Shionogi
- Target Recruit Count
- 14
- Registration Number
- NCT06106334
- Locations
- πΊπΈ
Fortrea Clinical Research Unit Inc., Dallas, Texas, United States
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants
- Conditions
- Gram-Negative Bacterial Infections
- Interventions
- Drug: Standard of Care
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Shionogi
- Target Recruit Count
- 30
- Registration Number
- NCT06086626
- Locations
- πΊπΈ
Arkansas Children's Hospital, Little Rock, Arkansas, United States
πΊπΈDuke University, Durham, North Carolina, United States
πΏπ¦Tygerberg Hospital, Cape Town, Western Cape, South Africa
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
- First Posted Date
- 2023-07-20
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Shionogi
- Target Recruit Count
- 627
- Registration Number
- NCT05953480
- Locations
- πΊπΈ
Munson Healthcare, Traverse City, Michigan, United States
πΊπΈMayo Clinic Hospital-Rochester, St. Marys Campus - PPDS, Rochester, Minnesota, United States
πΊπΈNuvance Health Medical Practice, PC- Neurosurgery, Great Neck, New York, United States